West Pharmaceutical Services(WST.US) Officer Sells US$24.2 Million in Common Stock
$West Pharmaceutical Services(WST.US)$ Officer Green Eric Mark sold 66,000 shares of common stock on May 7, 2024 at an average price of $366.6523 for a total value of $24.2 million.Source: Announcemen
West Pharmaceutical Services Insider Sold Shares Worth $24,199,050, According to a Recent SEC Filing
Eric Mark Green, Director, President, CEO and Board Chair, on May 07, 2024, sold 66,000 shares in West Pharmaceutical Services (WST) for $24,199,050. Following the Form 4 filing with the SEC, Green ha
Form 144 | West Pharmaceutical Services(WST.US) Officer Proposes to Sell 24.3 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 7, $West Pharmaceutical Services(WST.US)$ Officer Green Eric Mark intends to sell 66,000 shares of its common stock on May 7, with a total market value of approximately $24
Declining Stock and Solid Fundamentals: Is The Market Wrong About West Pharmaceutical Services, Inc. (NYSE:WST)?
It is hard to get excited after looking at West Pharmaceutical Services' (NYSE:WST) recent performance, when its stock has declined 8.2% over the past three months. However, a closer look at its sou
West to Participate in Upcoming Investor Conference
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
West Pharmaceutical Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423
West Pharmaceutical Services (WST) has an average outperform rating and a price target range of $336 to $470, according to analysts polled by Capital IQ. Price: 364.09, Change: -4.09, Percent Change:
West Pharmaceutical Services First Quarter 2024 Earnings: Beats Expectations
Earnings Call Summary | West Pharmaceutical Services(WST.US) Q1 2024 Earnings Conference
The following is a summary of the West Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings Call Transcript:Financial Performance:West Pharmaceutical Services reported a decrease in Q1 2024 net sales,
West Pharmaceutical Services: Strong Q1 Performance and Upbeat FY24 Outlook Bolster Buy Rating
West Pharmaceutical Services Inc (WST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
West Pharmaceutical Services To Go Ex-Dividend On July 31st, 2024 With 0.2 USD Dividend Per Share
April 26th - $West Pharmaceutical Services(WST.US)$ is trading ex-dividend on July 31st, 2024. Shareholders of record on July 31st, 2024 will receive 0.2 USD dividend per share on August 7th, 2024
West Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings Call Transcript
Research Alert: CFRA Maintains Hold Opinion On Shares Of West Pharmaceutical Services, Inc.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain a 12-month target price of $
Unusual Options Activity: GILD, DDOG and Others Attract Market Bets, GILD V/OI Ratio Reaches 1402.3
EST Apr 25th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
West Pharmaceutical Services Unveils Latest Financial Results
West Pharmaceutical Services (WST) Tops Q1 Earnings and Revenue Estimates
West Pharma 1Q EPS, Sales Top Views as Inventory Issues Ease
By Rob Curran West Pharmaceutical Services said its first-quarter earnings and sales topped Wall Street views as inventory issues eased. The Exton, Pa.-based provider of products and services to dru
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Posts Q1 EPS $1.56, Vs. Street Est of $1.29
06:34 AM EDT, 04/25/2024 (MT Newswires) -- Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Posts Q1 EPS $1.56, vs. Street Est of $1.29
West Pharmaceutical Services Reaffirms Full-year 2024 Net Sales Guidance of $3B-$3.025B Versus Consensus Of $3.01B
West Pharmaceutical Services Reaffirms Full-year 2024 Net Sales Guidance of $3B-$3.025B Versus Consensus Of $3.01B
No Data